Address
Email address
Phone number
Name
Sihtasutus Kõrva-Nina-Kurguhaiguste Kliinik
Registry code
90008421
VAT number
EE101249346
Type
SA - Foundation
Status
Registered
Foundation date
29.03.2004 (20)
Financial year
01.01-31.12
Activity
86221 - Provision of specialised medical treatment
-
-
-
936 €
(estimate is approximate)
-
24
Submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Oliver Vaide 02.11.1972 (52) | - | Board member | Exerciser of founder's rights, member of the supervisory board, board member | Founder |
| Sven Kivioja 22.01.1966 (58) | - | Board member | Exerciser of founder's rights, member of the supervisory board, board member | Founder |
| Piret Klaan 31.03.1973 (51) | - | - | Exerciser of founder's rights, member of the supervisory board, board member | Board member |
| Kristjan Kenapea 07.01.1973 (51) | - | - | Exerciser of founder's rights, member of the supervisory board, board member | Chairman of the board |
| Margus Luht 07.12.1958 (65) | - | - | Exerciser of founder's rights, member of the supervisory board, board member | FounderBoard member |
| Aet Saarts 13.04.1968 (56) | - | - | - | Founder |
| Aime Jesse 28.04.1942 (82) | - | - | - | Founder |
| Aino Allivere 29.01.1948 (76) | - | - | - | Founder |
| Annika Jussi 24.10.1963 (61) | - | - | - | Founder |
| Dmitri Dubrovin 26.05.1971 (53) | - | - | - | Founder |
| Ene Miller 19.12.1961 (62) | - | - | - | Founder |
| Kristel Kalling 27.11.1969 (54) | - | - | - | Founder |
| Liina Luht 25.11.1957 (66) | - | - | - | Founder |
| Mare Kalvet 11.03.1963 (61) | - | - | - | Founder |
| Marek Metsmaa 08.04.1973 (51) | - | - | - | Founder |
| Piibe Laane 31.12.1965 (58) | - | - | - | Founder |
| Reet Ani 31.01.1950 (74) | - | - | - | Founder |
| Urve Lekk 23.05.1954 (70) | - | - | - | Founder |
| Valdeko Pallav 19.07.1952 (72) | - | - | - | Founder |
| Ülle Kirss 02.09.1958 (66) | - | - | - | Founder |
| 2019 31.08.2020 | 2020 30.06.2021 | 2021 17.06.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - |
| Net profit (loss) for the period | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| Current Assets | 913 997 € | 1 150 579 € | 1 404 067 € | 1 336 499 € | 1 831 802 € |
| Fixed Assets | 466 747 € | 380 638 € | 322 986 € | 958 901 € | 1 017 556 € |
| Total Assets | 1 380 744 € | 1 531 217 € | 1 727 053 € | 2 295 400 € | 2 849 358 € |
| Current Liabilities | 221 389 € | 170 149 € | 219 314 € | 461 680 € | 403 272 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | - | - | - | - | - |
| Employees | 16 | 16 | 16 | 22 | 24 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 116 189.31 € | 245 466.23 € | 242 314.62 € | 36 |
| 2023 Q4 | 187 077.33 € | 212 115.67 € | 207 195.35 € | 37 |
| 2023 Q3 | 76 628.73 € | 176 055.59 € | 180 588.34 € | 32 |
| 2023 Q2 | 153 714.55 € | 199 048.57 € | 204 519 € | 33 |
| 2023 Q1 | 120 645.26 € | 152 666.63 € | 156 137.88 € | 32 |
| 2022 Q4 | 119 824.18 € | 127 879.47 € | 131 165.73 € | 32 |
| 2022 Q3 | 66 111.8 € | 116 139.79 € | 118 250.98 € | 30 |
| 2022 Q2 | 102 135.28 € | 108 580.46 € | 115 052.93 € | 30 |
| 2022 Q1 | 100 779.53 € | 143 744.59 € | 145 402.86 € | 31 |
| 2021 Q4 | 72 347.96 € | 108 195.87 € | 112 827.79 € | 31 |
| 2021 Q3 | 38 104.32 € | 121 885.6 € | 127 933.92 € | 31 |
| 2021 Q2 | 32 469.85 € | 91 662.39 € | 96 789.46 € | 31 |
| 2021 Q1 | 35 857.85 € | 116 052.23 € | 120 867.16 € | 38 |
| 2020 Q4 | 48 171.76 € | 95 533.66 € | 100 174.68 € | 38 |
| 2020 Q3 | 33 194.39 € | 95 126.7 € | 98 703.51 € | 36 |
| 2020 Q2 | 21 956.16 € | 89 860.58 € | 92 492.13 € | 35 |
| 2020 Q1 | 41 422.34 € | 134 472.13 € | 138 953.39 € | 35 |
